• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泊洛沙姆水凝胶作为可注射人工晶状体的生物相容性:一项初步研究。

Biocompatibility of poloxamer hydrogel as an injectable intraocular lens: a pilot study.

作者信息

Kwon Ji Won, Han Young Keun, Lee Woo Jin, Cho Chong Su, Paik Seung Joon, Cho Dong Il, Lee Jin Hak, Wee Won Ryang

机构信息

Department of Ophthalmology, Seoul National University College of Medicine, Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Korea.

出版信息

J Cataract Refract Surg. 2005 Mar;31(3):607-13. doi: 10.1016/j.jcrs.2004.05.051.

DOI:10.1016/j.jcrs.2004.05.051
PMID:15811752
Abstract

PURPOSE

To induce irreversible gelation of poloxamer, a thermosensitive polymer hydrogel, by using a photoinitiator and ultraviolet (UV) irradiation and to verify the biocompatibility and use of poloxamer as an injectable intraocular lens (IOL) material.

SETTING

Department of Ophthalmology, Seoul National University College of Medicine, Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.

METHODS

In 10 rabbits, endocapsular phacoemulsification was performed and a poloxamer-photoinitiator mixture was injected into the capsular bag through a small capsulorhexis site. In 1 eye, the capsulorhexis site was closed with a small plug and the entire eye was irradiated with UV light for 5 minutes. Postoperatively, poloxamer transparency and effect on the conjunctiva, cornea, iris, vitreous, and retina were observed.

RESULTS

A mixture comprising 25% poloxamer and 0.01% photoinitiator produced a poloxamer that remained transparent in the lens capsule for up to 6 months. No inflammatory response or toxicity was observed in the conjunctiva, cornea, iris, vitreous, or retina.

CONCLUSION

Poloxamer is a potentially suitable material for an injectable IOL. Further study is needed.

摘要

目的

通过使用光引发剂和紫外线(UV)照射诱导热敏性聚合物水凝胶泊洛沙姆发生不可逆凝胶化,并验证泊洛沙姆作为可注射人工晶状体(IOL)材料的生物相容性及用途。

设置

韩国首尔国立大学医学院眼科、首尔人工眼中心、首尔国立大学医院临床研究所。

方法

对10只兔子进行囊内超声乳化,并通过小的连续环形撕囊口将泊洛沙姆 - 光引发剂混合物注入囊袋内。在1只眼中,用小塞子封闭连续环形撕囊口,并用紫外线对整个眼睛照射5分钟。术后观察泊洛沙姆的透明度以及对结膜、角膜、虹膜、玻璃体和视网膜的影响。

结果

包含25%泊洛沙姆和0.01%光引发剂的混合物产生的泊洛沙姆在晶状体囊内可保持透明长达6个月。在结膜、角膜、虹膜、玻璃体或视网膜中未观察到炎症反应或毒性。

结论

泊洛沙姆是一种潜在适用于可注射人工晶状体的材料。尚需进一步研究。

相似文献

1
Biocompatibility of poloxamer hydrogel as an injectable intraocular lens: a pilot study.泊洛沙姆水凝胶作为可注射人工晶状体的生物相容性:一项初步研究。
J Cataract Refract Surg. 2005 Mar;31(3):607-13. doi: 10.1016/j.jcrs.2004.05.051.
2
One-year follow-up of bag-in-the-lens intraocular lens implantation in 60 eyes.60只眼的囊袋内人工晶状体植入术的一年随访
J Cataract Refract Surg. 2006 Oct;32(10):1632-7. doi: 10.1016/j.jcrs.2006.05.007.
3
Light-induced endocapsular polymerization of injectable lens refilling materials.可注射晶状体填充材料的光诱导囊内聚合。
Ger J Ophthalmol. 1992;1(5):346-9.
4
Anterior chamber depth and change in axial intraocular lens position after cataract surgery with primary posterior capsulorhexis and posterior optic buttonholing.白内障手术中采用原发性后囊连续环形撕囊和后房型人工晶状体光学部纽扣样撕开术后的前房深度及眼轴方向人工晶状体位置的变化
J Cataract Refract Surg. 2008 May;34(5):749-54. doi: 10.1016/j.jcrs.2007.12.035.
5
Retinal safety of the irradiation delivered to light-adjustable intraocular lenses evaluated in a rabbit model.评估于兔模型中的光调节型人工晶状体的辐照所致视网膜安全性。
J Cataract Refract Surg. 2010 Aug;36(8):1392-7. doi: 10.1016/j.jcrs.2010.02.018.
6
Routine posterior optic buttonholing for eradication of posterior capsule opacification in adults: report of 500 consecutive cases.成人常规后囊膜针刺术消除后囊膜混浊:500例连续病例报告
J Cataract Refract Surg. 2006 Jun;32(6):929-43. doi: 10.1016/j.jcrs.2006.02.046.
7
New photochromic foldable intraocular lens: preliminary study of feasibility and biocompatibility.新型光致变色可折叠人工晶状体:可行性与生物相容性的初步研究
J Cataract Refract Surg. 2006 Jul;32(7):1214-21. doi: 10.1016/j.jcrs.2006.01.105.
8
Uveal and capsular biocompatibility after implantation of sharp-edged hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in eyes with pseudoexfoliation syndrome.在假性剥脱综合征眼中植入边缘锐利的亲水性丙烯酸酯、疏水性丙烯酸酯和硅酮人工晶状体后的葡萄膜和囊膜生物相容性
J Cataract Refract Surg. 2007 Aug;33(8):1414-8. doi: 10.1016/j.jcrs.2007.05.009.
9
Biocompatibility of intraocular lens materials.人工晶状体材料的生物相容性。
Curr Opin Ophthalmol. 2008 Jan;19(1):41-9. doi: 10.1097/ICU.0b013e3282f20132.
10
Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens.蓝光滤过型AcrySof Natural可折叠丙烯酸酯人工晶状体的临床结果。
J Cataract Refract Surg. 2005 Dec;31(12):2319-23. doi: 10.1016/j.jcrs.2004.11.061.

引用本文的文献

1
An injectable PEG hydrogel controlling neurotrophin-3 release by affinity peptides.一种通过亲和肽控制神经营养因子 3 释放的可注射 PEG 水凝胶。
J Control Release. 2021 Feb 10;330:575-586. doi: 10.1016/j.jconrel.2020.12.045. Epub 2020 Dec 27.
2
Advances in the Study of Lens Refilling.晶状体再填充研究进展
J Ophthalmol. 2020 Aug 26;2020:8956275. doi: 10.1155/2020/8956275. eCollection 2020.
3
Injectable hydrogels for ophthalmic applications.眼科应用的可注射水凝胶。
J Control Release. 2017 Dec 28;268:212-224. doi: 10.1016/j.jconrel.2017.10.031. Epub 2017 Oct 20.
4
A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.单次CT引导下经皮骨内注射热敏性辛伐他汀/泊洛沙姆407水凝胶可增强去卵巢小型猪的椎体骨形成。
Osteoporos Int. 2016 Feb;27(2):757-67. doi: 10.1007/s00198-015-3230-y. Epub 2015 Jul 30.
5
Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(ε-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127.原位凝胶水凝胶的体内眼内生物相容性研究:聚(2-乙基恶唑啉)-嵌段-聚(ε-己内酯)-嵌段-聚(2-乙基恶唑啉)共聚物、基质胶和泊洛沙姆 F127。
PLoS One. 2013 Jul 1;8(7):e67495. doi: 10.1371/journal.pone.0067495. Print 2013.
6
A review of poloxamer 407 pharmaceutical and pharmacological characteristics.泊洛沙姆407的药学和药理学特性综述。
Pharm Res. 2006 Dec;23(12):2709-28. doi: 10.1007/s11095-006-9104-4. Epub 2006 Nov 11.